| Arnold Eyecare Center | |
|
1235 Water Tower Pl, Arnold, MO 63010-2142 | |
| (636) 296-8612 | |
| (636) 296-8055 |
| Full Name | Arnold Eyecare Center |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 1235 Water Tower Pl, Arnold, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770619637 | NPI | - | NPPES |
| 410035835 | Other | MO | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | TO2765 (Missouri) | Primary |
| Provider Name | Carrie C Riley |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1801096532 PECOS PAC ID: 2668556770 Enrollment ID: I20080228000211 |
News Archive
Skin is the body's armor, protecting us from disease agents, injury, excessive water loss, and cold and heat. Yet mutations in a single gene, the gene for the protein p63, cause numerous diseases and malformations of the uppermost layer of skin - the epidermis - and other tissues. In the epidermis, these range from skin cancers to dysplasias that cause cracking, bleeding, infection, and discoloration.
An innovative treatment for HIV patients developed by McGill University Health Centre researchers has passed its first clinical trial with flying colours. The new approach is an immunotherapy customized for each individual patient, and was developed by Dr. J-P. Routy from the Research Institute of the MUHC in collaboration with Dr. R. S-kaly from the Universit- de Montr-al.
Public health officials and health care providers need to step up their efforts to reduce Americans' increasing rates of high blood pressure and better treat those with the condition, which triggers more than one-third of heart attacks and almost half of heart failures in the United States each year, says a new report from the Institute of Medicine.
An article published in Experimental Biology and Medicine identifies a new signaling pathway involved in breast cancer cell growth. The study, led by Dr. Chan-Wha Kim, from the Department of Biotechnology at Korea University in Seoul, reports that inhibition of the actin-binding protein transgelin prevents vasculogenic mimicry (VM), a process that provides tumor cells with the nutrients required for growth.
A team of Mayo Clinic researchers have found that hypoxia can be detected prior to incapacitating physical symptoms which can be a safety threat at high altitudes. The findings were published as the lead article in the October issue of Aviation, Space, and Environmental Medicine.
› Verified 8 days ago
| Provider Name | Diane G Wilson |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1841236635 PECOS PAC ID: 7416020235 Enrollment ID: I20100513001043 |
News Archive
Skin is the body's armor, protecting us from disease agents, injury, excessive water loss, and cold and heat. Yet mutations in a single gene, the gene for the protein p63, cause numerous diseases and malformations of the uppermost layer of skin - the epidermis - and other tissues. In the epidermis, these range from skin cancers to dysplasias that cause cracking, bleeding, infection, and discoloration.
An innovative treatment for HIV patients developed by McGill University Health Centre researchers has passed its first clinical trial with flying colours. The new approach is an immunotherapy customized for each individual patient, and was developed by Dr. J-P. Routy from the Research Institute of the MUHC in collaboration with Dr. R. S-kaly from the Universit- de Montr-al.
Public health officials and health care providers need to step up their efforts to reduce Americans' increasing rates of high blood pressure and better treat those with the condition, which triggers more than one-third of heart attacks and almost half of heart failures in the United States each year, says a new report from the Institute of Medicine.
An article published in Experimental Biology and Medicine identifies a new signaling pathway involved in breast cancer cell growth. The study, led by Dr. Chan-Wha Kim, from the Department of Biotechnology at Korea University in Seoul, reports that inhibition of the actin-binding protein transgelin prevents vasculogenic mimicry (VM), a process that provides tumor cells with the nutrients required for growth.
A team of Mayo Clinic researchers have found that hypoxia can be detected prior to incapacitating physical symptoms which can be a safety threat at high altitudes. The findings were published as the lead article in the October issue of Aviation, Space, and Environmental Medicine.
› Verified 8 days ago
| Provider Name | Amy L Schaag |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1356867816 PECOS PAC ID: 4880958073 Enrollment ID: I20180516002282 |
News Archive
Skin is the body's armor, protecting us from disease agents, injury, excessive water loss, and cold and heat. Yet mutations in a single gene, the gene for the protein p63, cause numerous diseases and malformations of the uppermost layer of skin - the epidermis - and other tissues. In the epidermis, these range from skin cancers to dysplasias that cause cracking, bleeding, infection, and discoloration.
An innovative treatment for HIV patients developed by McGill University Health Centre researchers has passed its first clinical trial with flying colours. The new approach is an immunotherapy customized for each individual patient, and was developed by Dr. J-P. Routy from the Research Institute of the MUHC in collaboration with Dr. R. S-kaly from the Universit- de Montr-al.
Public health officials and health care providers need to step up their efforts to reduce Americans' increasing rates of high blood pressure and better treat those with the condition, which triggers more than one-third of heart attacks and almost half of heart failures in the United States each year, says a new report from the Institute of Medicine.
An article published in Experimental Biology and Medicine identifies a new signaling pathway involved in breast cancer cell growth. The study, led by Dr. Chan-Wha Kim, from the Department of Biotechnology at Korea University in Seoul, reports that inhibition of the actin-binding protein transgelin prevents vasculogenic mimicry (VM), a process that provides tumor cells with the nutrients required for growth.
A team of Mayo Clinic researchers have found that hypoxia can be detected prior to incapacitating physical symptoms which can be a safety threat at high altitudes. The findings were published as the lead article in the October issue of Aviation, Space, and Environmental Medicine.
› Verified 8 days ago
| Provider Name | Jon R Wilzonski |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1063074540 PECOS PAC ID: 7315274511 Enrollment ID: I20190812000304 |
News Archive
Skin is the body's armor, protecting us from disease agents, injury, excessive water loss, and cold and heat. Yet mutations in a single gene, the gene for the protein p63, cause numerous diseases and malformations of the uppermost layer of skin - the epidermis - and other tissues. In the epidermis, these range from skin cancers to dysplasias that cause cracking, bleeding, infection, and discoloration.
An innovative treatment for HIV patients developed by McGill University Health Centre researchers has passed its first clinical trial with flying colours. The new approach is an immunotherapy customized for each individual patient, and was developed by Dr. J-P. Routy from the Research Institute of the MUHC in collaboration with Dr. R. S-kaly from the Universit- de Montr-al.
Public health officials and health care providers need to step up their efforts to reduce Americans' increasing rates of high blood pressure and better treat those with the condition, which triggers more than one-third of heart attacks and almost half of heart failures in the United States each year, says a new report from the Institute of Medicine.
An article published in Experimental Biology and Medicine identifies a new signaling pathway involved in breast cancer cell growth. The study, led by Dr. Chan-Wha Kim, from the Department of Biotechnology at Korea University in Seoul, reports that inhibition of the actin-binding protein transgelin prevents vasculogenic mimicry (VM), a process that provides tumor cells with the nutrients required for growth.
A team of Mayo Clinic researchers have found that hypoxia can be detected prior to incapacitating physical symptoms which can be a safety threat at high altitudes. The findings were published as the lead article in the October issue of Aviation, Space, and Environmental Medicine.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Arnold Eyecare Center 1235 Water Tower Pl, Arnold, MO 63010-2142 Ph: (636) 296-8612 | Arnold Eyecare Center 1235 Water Tower Pl, Arnold, MO 63010-2142 Ph: (636) 296-8612 |
News Archive
Skin is the body's armor, protecting us from disease agents, injury, excessive water loss, and cold and heat. Yet mutations in a single gene, the gene for the protein p63, cause numerous diseases and malformations of the uppermost layer of skin - the epidermis - and other tissues. In the epidermis, these range from skin cancers to dysplasias that cause cracking, bleeding, infection, and discoloration.
An innovative treatment for HIV patients developed by McGill University Health Centre researchers has passed its first clinical trial with flying colours. The new approach is an immunotherapy customized for each individual patient, and was developed by Dr. J-P. Routy from the Research Institute of the MUHC in collaboration with Dr. R. S-kaly from the Universit- de Montr-al.
Public health officials and health care providers need to step up their efforts to reduce Americans' increasing rates of high blood pressure and better treat those with the condition, which triggers more than one-third of heart attacks and almost half of heart failures in the United States each year, says a new report from the Institute of Medicine.
An article published in Experimental Biology and Medicine identifies a new signaling pathway involved in breast cancer cell growth. The study, led by Dr. Chan-Wha Kim, from the Department of Biotechnology at Korea University in Seoul, reports that inhibition of the actin-binding protein transgelin prevents vasculogenic mimicry (VM), a process that provides tumor cells with the nutrients required for growth.
A team of Mayo Clinic researchers have found that hypoxia can be detected prior to incapacitating physical symptoms which can be a safety threat at high altitudes. The findings were published as the lead article in the October issue of Aviation, Space, and Environmental Medicine.
› Verified 8 days ago
Clarkson Optometry, Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 28 Arnold Mall, Arnold, MO 63010 Phone: 636-282-2700 | |
Clarkson Eyecare Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3936 Vogel Rd, Arnold, MO 63010 Phone: 636-200-4393 Fax: 636-296-3376 | |
Jon R Wilzonski, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1235 Water Tower Pl, Arnold, MO 63010 Phone: 636-296-8612 Fax: 636-296-8055 | |
Christopher M Schrick Od Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3849 Vogel Rd, Arnold, MO 63010 Phone: 636-287-1793 Fax: 636-287-1844 | |
Crown Optical Optometrist Medicare: Not Enrolled in Medicare Practice Location: 856 Arnold Commons Dr, Arnold, MO 63010 Phone: 314-741-8183 Fax: 314-741-4947 | |
Mohammed Salman, OD Optometrist Medicare: Medicare Enrolled Practice Location: 28 Arnold Mall, Arnold, MO 63010 Phone: 636-282-2700 | |
20-20 Vision Care Optometrist Medicare: Not Enrolled in Medicare Practice Location: 28 Arnold Mall, Arnold, MO 63010 Phone: 636-282-2700 Fax: 636-282-3084 |